Search

Your search keyword '"Saieva, C."' showing total 592 results
Start Over Author "Saieva, C."
592 results on '"Saieva, C."'

2. Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort

Author

Obón-Santacana, M, Kaaks, R, Slimani, N, Lujan-Barroso, L, Freisling, H, Ferrari, P, Dossus, L, Chabbert-Buffet, N, Baglietto, L, Fortner, RT, Boeing, H, Tjønneland, A, Olsen, A, Overvad, K, Menéndez, V, Molina-Montes, E, Larrañaga, N, Chirlaque, M-D, Ardanaz, E, Khaw, K-T, Wareham, N, Travis, RC, Lu, Y, Merritt, MA, Trichopoulou, A, Benetou, V, Trichopoulos, D, Saieva, C, Sieri, S, Tumino, R, Sacerdote, C, Galasso, R, Bueno-de-Mesquita, HB, Wirfält, E, Ericson, U, Idahl, A, Ohlson, N, Skeie, G, Gram, IT, Weiderpass, E, Onland-Moret, NC, Riboli, E, and Duell, EJ

Subjects
Biomedical and Clinical Sciences, Nutrition and Dietetics, Nutrition, Clinical Research, Prevention, Cancer, Aetiology, 2.2 Factors relating to the physical environment, Cardiovascular, Acrylamide, Cohort Studies, Diet, Eating, Endometrial Neoplasms, Female, Humans, Middle Aged, Nutritional Status, Prospective Studies, Risk, Risk Factors, Smoking, acrylamide, endometrial cancer, type-I endometrial cancer, cohort, nutrition, Oncology and Carcinogenesis, Public Health and Health Services, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

BackgroundThree prospective studies have evaluated the association between dietary acrylamide intake and endometrial cancer (EC) risk with inconsistent results. The objective of this study was to evaluate the association between acrylamide intake and EC risk: for overall EC, for type-I EC, and in never smokers and never users of oral contraceptives (OCs). Smoking is a source of acrylamide, and OC use is a protective factor for EC risk.MethodsCox regression was used to estimate hazard ratios (HRs) for the association between acrylamide intake and EC risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Acrylamide intake was estimated from the EU acrylamide monitoring database, which was matched with EPIC questionnaire-based food consumption data. Acrylamide intake was energy adjusted using the residual method.ResultsNo associations were observed between acrylamide intake and overall EC (n=1382) or type-I EC risk (n=627). We observed increasing relative risks for type-I EC with increasing acrylamide intake among women who both never smoked and were non-users of OCs (HRQ5vsQ1: 1.97, 95% CI: 1.08-3.62; likelihood ratio test (LRT) P-value: 0.01, n=203).ConclusionsDietary intake of acrylamide was not associated with overall or type-I EC risk; however, positive associations with type I were observed in women who were both non-users of OCs and never smokers.

Published
2014

3. Cardioprotection beyond the guidelines: the SAFE trial results

Author

Barletta, G, primary, Meattini, I, additional, Del Bene, M R, additional, Martella, F, additional, Becherini, C, additional, Pilato, G, additional, Visani, L, additional, Salvestrini, V, additional, Airoldi, M, additional, Amoroso, D, additional, Coltelli, L, additional, Parisi, F, additional, Saieva, C, additional, and Livi, L, additional

Published
2023
Full Text
View/download PDF

5. Gender and cystectomy for bladder cancer: A high-volume tertiary urologic care center experience

Author

Mariotti, A., primary, Spatafora, P., additional, Sessa, F., additional, Saieva, C., additional, Galli, I.C., additional, Roviello, G., additional, Doni, L., additional, Zaccaro, C., additional, Bisegna, C., additional, Conte, F.L., additional, Mariottini, R., additional, Marzocco, A., additional, Masieri, L., additional, Vignolini, G., additional, Minervini, A., additional, Serni, S., additional, Carini, M., additional, Nesi, G., additional, and Villari, D., additional

Published
2023
Full Text
View/download PDF

8. Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study

Author

Bonomo, P., Merlotti, A., Morbelli, S., Berti, V., Saieva, C., Bergesio, F., Bacigalupo, A., Belgioia, L., Franzese, C., Lopci, E., Casolo, A., D’Angelo, E., Alterio, D., Travaini, L., Berretta, L., Pirro, V., Ursino, S., Volterrani, D., Roncali, M., Vigo, F., Cicchetti, S., Scalone, F., Belli, G., Cauda, S., Desideri, I., Russi, E., Livi, L., and Bianchi, A.

Published
2020
Full Text
View/download PDF

10. 231P Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer

Author

Visani, L., primary, Becherini, C., additional, Scoccimarro, E., additional, Valzano, M., additional, Saieva, C., additional, Ratosa, I., additional, Ribnikar, D., additional, Orazem, M., additional, Marinko, T., additional, Desideri, I., additional, Scotti, V., additional, Morandi, A., additional, Lambertini, M., additional, Meattini, I., additional, and Livi, L., additional

Published
2022
Full Text
View/download PDF

11. Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

Author

Obón-Santacana, M., Slimani, N., Lujan-Barroso, L., Travier, N., Hallmans, G., Freisling, H., Ferrari, P., Boutron-Ruault, M.C., Racine, A., Clavel, F., Saieva, C., Pala, V., Tumino, R., Mattiello, A., Vineis, P., Argüelles, M., Ardanaz, E., Amiano, P., Navarro, C., Sánchez, M.J., Molina Montes, E., Key, T., Khaw, K.-T., Wareham, N., Peeters, P.H., Trichopoulou, A., Bamia, C., Trichopoulos, D., Boeing, H., Kaaks, R., Katzke, V., Ye, W., Sund, M., Ericson, U., Wirfält, E., Overvad, K., Tjønneland, A., Olsen, A., Skeie, G., Åsli, L.A., Weiderpass, E., Riboli, E., Bueno-de-Mesquita, H.B., and Duell, E.J.

Published
2013
Full Text
View/download PDF

13. Alcohol consumption and the risk of renal cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC). Wozniak MB, Brennan P, Brenner DR, Overvad K, Olsen A, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Katzke V, Kühn T, Boeing H, Bergmann MM, Steffen A, Naska A, Trichopoulou A, Trichopoulos D, Saieva C, Grioni S, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Hjartåker A, Weiderpass E, Arriola L, Molina-Montes E, Duell EJ, Santiuste C, Alonso de la Torre R, Barricarte Gurrea A, Stocks T, Johansson M, Ljungberg B, Wareham N, Khaw KT, Travis RC, Cross AJ, Murphy N, Riboli E, Scelo G.Int J Cancer. 2015 Oct 15;137(8):1953-66. [Epub 2015 Apr 28]. doi: 10.1002/ijc.29559.

Author

Jay, Raman, Brennan, P, Brenner, Overvad, K, Olsen, A, Tjønneland, A, Boutron-Ruault, MC, Clavel-Chapelon, F, Fagherazzi, Katzke, V, Kühn, T, Boeing, H, Bergmann, MM, Steffen, A, Naska, A, Trichopoulou, A, Trichopoulos, D, Saieva, C, Grioni, S, Panico, S, Tumino, R, Vineis, P, Bueno-de-Mesquita, HB, Peeters, PH, Hjartåker, A, Weiderpass, E, Arriola, L, Molina-Montes, E, Duell, EJ, Santiuste, C, Alonso de la Torre, R, Barricarte Gurrea, A, Stocks, T, Johansson, M, Ljungberg, B, Wareham, N, Khaw, KT, Travis, RC, Cross, AJ, Murphy, N, Riboli, E, and Scelo, G

Published
2017
Full Text
View/download PDF

15. Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study

Author

Abbas, S, Linseisen, J, Rohrmann, S, Beulens, J W J, Buijsse, B, Amiano, P, Ardanaz, E, Balkau, B, Boeing, H, Clavel-Chapelon, F, Fagherazzi, G, Franks, P W, Gavrila, D, Grioni, S, Kaaks, R, Key, T J, Khaw, K T, Kühn, T, Mattiello, A, Molina-Montes, E, Nilsson, P M, Overvad, K, Quirós, J R, Rolandsson, O, Sacerdote, C, Saieva, C, Slimani, N, Sluijs, I, Spijkerman, A M W, Tjonneland, A, Tumino, R, van der A, D L, Zamora-Ros, R, Sharp, S J, Langenberg, C, Forouhi, N G, Riboli, E, and Wareham, N J

Published
2014
Full Text
View/download PDF

18. Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy

Author

Ottini, L., Silvestri, V., Saieva, C., Rizzolo, P., Zanna, I., Falchetti, M., Masala, G., Navazio, A. S., Graziano, V., Bianchi, S., Manoukian, S., Barile, M., Peterlongo, P., D’Amico, C., Varesco, L., Tommasi, S., Russo, A., Giannini, G., Cortesi, L., Viel, A., Montagna, M., Radice, P., and Palli, D.

Published
2013
Full Text
View/download PDF

19. 242P Impact of metastases directed radiation therapy on CDK4/6 inhibitors treatment for metastatic breast cancer

Author

Meattini, I., primary, Visani, L., additional, Ratosa, I., additional, Saieva, C., additional, Ribnikar, D., additional, Scoccimarro, E., additional, Becherini, C., additional, Orazem, M., additional, Stocchi, G., additional, Bellini, C., additional, Lorenzetti, V., additional, Orsatti, C., additional, Angelini, L., additional, Desideri, I., additional, Scotti, V., additional, Morandi, A., additional, Marinko, T., additional, and Livi, L., additional

Published
2021
Full Text
View/download PDF

20. OC-0071 Safety and efficacy of concomitant radiation and CDK4/6 inhibitors in breast cancer patients

Author

Visani, L., primary, Ratosa, I., additional, Scoccimarro, E., additional, Becherini, C., additional, Saieva, C., additional, Desideri, I., additional, Scotti, V., additional, Ozarem, M., additional, Ribnikar, D., additional, Aquilano, M., additional, Cerbai, C., additional, Orzalesi, L., additional, Bernini, M., additional, Sanchez, L., additional, Nori, J., additional, Bianchi, S., additional, Meattini, I., additional, and Livi, L., additional

Published
2021
Full Text
View/download PDF

23. Alcohol consumption patterns, diet and body weight in 10 European countries

Author

Sieri, S., Krogh, V., Saieva, C., Grobbee, D.E., Bergmann, M., Rohrmann, S., Tjonneland, A., Ferrari, P., Chloptsios, Y., Dilis, V., Jenab, M., Linseisen, J., Wallstrom, P., Johansson, I., Chirlaque, M.D., Sanchez, M.J., Niravong, M., Clavel-Chapelon, F., Welch, A.A., Allen, N.E., Bueno-de-Mesquita, H.B., van der Schouw, Y.T., Sacerdote, C., Panico, S., Parr, C.L., Braaten, T., Olsen, A., Jensen, M.K., Bingham, S., Riboli, E., and Slimani, N.

Subjects
Drinking of alcoholic beverages -- Health aspects -- Demographic aspects -- Analysis, Body weight -- Analysis -- Health aspects, Diet -- Health aspects -- Analysis, Food/cooking/nutrition, Health
Abstract

Background/objectives: Europe has the highest level of alcohol consumption in the world. As drinking patterns are important determinants of the beneficial and harmful effects of alcohol consumption, we investigated alcohol consumption in relation to nutrient intake, place of consumption, education and body weight in a sample of adults from 10 European countries. Methods: A 24-h dietary recall interview was conducted on 13 025 men and 23 009 women, aged 35-74 years, from 27 centres participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Means and standard errors of alcohol consumption, adjusted for age, were calculated, stratified by gender and centre. Results: In many centres, higher level drinkers (males consuming >24 g of ethanol/day, equivalent to 42 standard drinks and females consuming >12 g of ethanol/day equivalent to >1 standard drink) obtained more energy from fat and protein and less from sugar than did abstainers. The proportion of energy from starch tended to be higher for male and lower for female higher level drinkers than for abstainers. Female higher level drinkers had a lower body mass index than did abstainers, whereas male higher level drinkers generally weighed more. Male higher level drinkers were less educated than abstainers in Mediterranean countries, but were more educated elsewhere. Female higher level drinkers were usually more educated than were abstainers. Outside the home, consumption (both genders) tended to be at friends' homes, particularly among men in Northern and Central Europe, and in bars in Spain. Conclusions: This study reveals clear geographical differences in drinking habits across Europe, and shows that the characteristics of different alcohol consumption categories also vary. doi: 10.1038/ejcn.2009.76 Keywords: Alcohol; EPIC; 24-h dietary recall; EPIC-Soft; ENDB, Introduction Europe has the highest level of alcohol consumption in the world (Rehm et al., 2003a). Studies on drinking patterns across Europe, in terms of place of consumption, types of [...]

Published
2009
Full Text
View/download PDF

24. Assessing preferences in patients with head and neck squamous cell carcinoma: Phase i and ii of questionnaire development

Author

Bonomo, P. Maruelli, A. Saieva, C. Taylor, K. Singer, S. Patelli, Z. Rogers, S. Mattavelli, D. Simon, C. Scotté, F. de Oliveira, T.B. Murphy, B. Rhoten, B.A. Tassini, U. Fallon, M. Galitis, O.N. Yarom, N. Bergamini, C. Bossi, P.

Abstract

Shared-decision making for head and neck squamous cell carcinoma (HNSCC) is challenged by the difficulty to integrate the patient perception of value within the framework of a multidisciplinary team approach. The aim of this study was to develop a questionnaire to assess the preferences of HNSCC patients with respect to the disease trajectory, expected treatment, and toxicities. In accordance with the standardized EORTC Quality of Life Group’s methodology for the development of quality of life modules, a phase 1–2 study was envisaged. Following a systematic review of the literature, a consolidated list of 28 issues was administered through a semi-structured interview to 111 patients from 7 institutions in 5 countries. Overall, “cure of disease”, “survival”, and “trusting in health care professionals” were the 3 most common priorities, being chosen by 87.3%, 73.6% and 59.1% of patients, respectively. When assessing the correlation with the treatment subgroup, the issue of “being thoroughly and sincerely informed about treatments’ efficacy and survival expectation” was highly prevalent in an independent manner (71.4%, 75% and 90% of patients in the follow-up, palliative and curative subgroups, respectively). Based on prespecified scoring criteria, a 24-item list was generated. Pending clinical applicability, further testing and validation of the questionnaire are warranted. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.

Published
2020

28. PH-0040: A 6-point scale approach to 18F-FDG PET-CT for response assessment in HNSCC: a multicenter study

Author

Bonomo, P., primary, Merlotti, A., additional, Morbelli, S., additional, Berti, V., additional, Saieva, C., additional, Bergesio, F., additional, Bacigalupo, A., additional, Belgioia, L., additional, Franzese, C., additional, Lopci, E., additional, Casolo, A., additional, D'Angelo, E., additional, Alterio, D., additional, Travaini, L., additional, Berretta, L., additional, Pirro, V., additional, Ursino, S., additional, Volterrani, D., additional, Roncali, M., additional, Vigo, F., additional, Desideri, I., additional, Russi, E., additional, Livi, L., additional, and Bianchi, A., additional

Published
2020
Full Text
View/download PDF

29. PO-0928: Safety and efficacy of concomitant RT and CDK4/6 inhibitors in metastatic breast cancer patients.

Author

Visani, L., primary, Saieva, C., additional, Desideri, I., additional, Scotti, V., additional, Dominici, L., additional, Scoccimarro, E., additional, Aquilano, M., additional, Cerbai, C., additional, Palmieri, V.E., additional, Maragna, V., additional, Becherini, C., additional, Bernini, M., additional, Sanchez, L., additional, Orzalesi, L., additional, Nori, J., additional, Antonuzzo, L., additional, Bianchi, S., additional, Meattini, I., additional, and Livi, L., additional

Published
2020
Full Text
View/download PDF

30. 978TiP Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase I/II trial

Author

Bonomo, P., primary, Desideri, I., additional, Mangoni, M., additional, Loi, M., additional, Saieva, C., additional, Marrazzo, L., additional, Talamonti, C., additional, Salvatore, G., additional, Sottili, M., additional, Teriaca, M.A., additional, Stocchi, G., additional, Cerbai, C., additional, Salvestrini, V., additional, Ganovelli, M., additional, Massi, D., additional, Gallo, O., additional, Santoro, R., additional, Spinelli, G., additional, Pallotta, S., additional, and Livi, L., additional

Published
2020
Full Text
View/download PDF

37. Separate and combined associations of obesity and metabolic health with coronary heart disease: A pan-European case-cohort analysis

Author

Lassale, C. Tzoulaki, I. Moons, K.G.M. Sweeting, M. Boer, J. Johnson, L. Huerta, J.M. Agnoli, C. Freisling, H. Weiderpass, E. Wennberg, P. Van Der A, D.L. Arriola, L. Benetou, V. Boeing, H. Bonnet, F. Colorado-Yohar, S.M. Engström, G. Eriksen, A.K. Ferrari, P. Grioni, S. Johansson, M. Kaaks, R. Katsoulis, M. Katzke, V. Key, T.J. Matullo, G. Melander, O. Molina-Portillo, E. Moreno-Iribas, C. Norberg, M. Overvad, K. Panico, S. Quiros, J.R. Saieva, C. Skeie, G. Steffen, A. Stepien, M. Tjønneland, A. Trichopoulou, A. Tumino, R. Van Der Schouw, Y.T. Verschuren, W.M.M. Langenberg, C. Di Angelantonio, E. Riboli, E. Wareham, N.J. Danesh, J. Butterworth, A.S.

Abstract

Aims: The hypothesis of 'metabolically healthy obesity' implies that, in the absence of metabolic dysfunction, individuals with excess adiposity are not at greater cardiovascular risk We tested this hypothesis in a large pan-European prospective study. Methods and results: We conducted a case-cohort analysis in the 520 000-person European Prospective Investigation into Cancer and Nutrition study ('EPIC-CVD'). During a median follow-up of 12.2 years, we recorded 7637 incident coronary heart disease (CHD) cases. Using cut-offs recommended by guidelines, we defined obesity and overweight using body mass index (BMI), and metabolic dysfunction ('unhealthy') as ≥3 of elevated blood pressure, hypertriglyceridaemia, low HDL-cholesterol, hyperglycaemia, and elevated waist circumference. We calculated hazard ratios (HRs) and 95% confidence intervals (95% CI) within each country using Prentice-weighted Cox proportional hazard regressions, accounting for age, sex, centre, education, smoking, diet, and physical activity. Compared with metabolically healthy normal weight people (reference), HRs were 2.15 (95% CI: 1.79; 2.57) for unhealthy normal weight, 2.33 (1.97; 2.76) for unhealthy overweight, and 2.54 (2.21; 2.92) for unhealthy obese people. Compared with the reference group, HRs were 1.26 (1.14; 1.40) and 1.28 (1.03; 1.58) for metabolically healthy overweight and obese people, respectively. These results were robust to various sensitivity analyses. Conclusion: Irrespective of BMI, metabolically unhealthy individuals had higher CHD risk than their healthy counterparts. Conversely, irrespective of metabolic health, overweight and obese people had higher CHD risk than lean people. These findings challenge the concept of 'metabolically healthy obesity', encouraging population-wide strategies to tackle obesity. © The Author 2017.

Published
2018

38. Safety of hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: A multi-center comparative study

Author

Meattini, I., primary, Livi, L., additional, Kim, K., additional, Kim, J., additional, Jung, W., additional, Olmetto, E., additional, Desideri, I., additional, Saieva, C., additional, Becherini, C., additional, Salvestrini, V., additional, Fourquet, A., additional, Kirova, Y., additional, and Poortmans, P., additional

Published
2019
Full Text
View/download PDF

39. Pre-specified interim analysis of the SAFE trial (NCT2236806): A 4-arm randomized, double-blind, controlled study evaluating the efficacy and safety of cardiotoxicity prevention in non-metastatic breast cancer patients treated with anthracyclines with or without trastuzumab

Author

Livi, L., primary, Barletta, G., additional, Martella, F., additional, Desideri, I., additional, Scotti, V., additional, Becherini, C., additional, Saieva, C., additional, Terziani, F., additional, Bacci, C., additional, Airoldi, M., additional, Allegrini, G., additional, Amoroso, D., additional, Venditti, F., additional, Tarquini, R., additional, Orzalesi, L., additional, Sanchez, L., additional, Bernini, M., additional, Nori, J., additional, Fioretto, L., additional, and Meattini, I., additional

Published
2019
Full Text
View/download PDF

41. PO-0750 VMAT for CNS Tumors and alopecia:results of an observational study and new constraints for the SCALP

Author

Scoccianti, S., primary, Grassi, R., additional, Marco, P., additional, Terziani, F., additional, Simontacchi, G., additional, Talamonti, C., additional, Caramia, G., additional, Russo, M. Lo, additional, Teriaca, M.A., additional, Scoccimarro, E., additional, Saieva, C., additional, Cosi, L., additional, Pallotta, S., additional, and Livi, L., additional

Published
2019
Full Text
View/download PDF

42. Abstract P3-12-07: Conservative breast reconstruction: Outcomes of 146 consecutive cases of prepectoral, subcutaneous implant-based breast reconstruction in a single-Institution series

Author

Meattini, I, primary, Bernini, M, additional, Saieva, C, additional, Desideri, I, additional, Scotti, V, additional, Salvestrini, V, additional, Visani, L, additional, Mariotti, M, additional, Delli Paoli, C, additional, Olmetto, E, additional, Maragna, V, additional, Orzalesi, L, additional, Sanchez, L, additional, Nori, J, additional, Bianchi, S, additional, and Livi, L, additional

Published
2019
Full Text
View/download PDF

43. Abstract P4-16-04: Oral ibandronate for osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: secondary 5-year survival outcomes analysis of the single-center phase 2 BONADIUV trial

Author

Meattini, I, primary, Scotti, V, additional, Desideri, I, additional, Saieva, C, additional, Visani, L, additional, Salvestrini, V, additional, Cecchini, S, additional, De Feo, ML, additional, Mariotti, M, additional, Olmetto, E, additional, Delli Paoli, C, additional, Francolini, G, additional, Bernini, M, additional, Orzalesi, L, additional, Sanchez, L, additional, Nori, J, additional, Bianchi, S, additional, and Livi, L, additional

Published
2019
Full Text
View/download PDF

48. Ductal carcinoma in situ treated with breast conservative surgery and radiotherapy: A national multicentre experience

Author

Meattini, I., primary, Pasinetti, N., additional, Meduri, B., additional, De Rose, F., additional, De Santis, M.C., additional, Lancellotta, V., additional, Rossi, F., additional, Franco, P., additional, Alongi, F., additional, Saieva, C., additional, Delli Paoli, C., additional, Desideri, I., additional, D’angelo, E., additional, Triggiani, L., additional, Ricardi, U., additional, Bastiani, P., additional, Aristei, C., additional, Lozza, L., additional, Scorsetti, M., additional, and Livi, L., additional

Published
2018
Full Text
View/download PDF

49. OC-0160: DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience

Author

Meattini, I., primary, Pasinetti, N., additional, Meduri, B., additional, De Rose, F., additional, De Santis, M.C., additional, Lancellotta, V., additional, Rossi, F., additional, Franco, P., additional, Alongi, F., additional, Saieva, C., additional, Olmetto, E., additional, Desideri, I., additional, D'Angelo, E., additional, Triggiani, L., additional, Ricardi, U., additional, Bastiani, P., additional, Aristei, C., additional, Lozza, L., additional, Scorsetti, M., additional, and Livi, L., additional

Published
2018
Full Text
View/download PDF

50. Alcohol consumption and the risk of renal cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC). Wozniak MB, Brennan P, Brenner DR, Overvad K, Olsen A, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Katzke V, Kühn T, Boeing H, Bergmann MM, Steffen A, Naska A, Trichopoulou A, Trichopoulos D, Saieva C, Grioni S

Author

Jay, Raman, Brennan, P., Brenner, X., Overvad, K., Olsen, A., Tjønneland, A., Boutron-Ruault, M. C., Clavel-Chapelon, F., Fagherazzi, X., Katzke, V., Kühn, T., Boeing, H., Bergmann, M. M., Steffen, A., Naska, A., Trichopoulou, A., Trichopoulos, D., Saieva, C., Grioni, S., Panico, S., Tumino, R., Vineis, P., Bueno-de-Mesquita, H. B., Hjartåker, A., Peeters, P. H., Weiderpass, E., Arriola, L., Molina-Montes, E., Duell, E. J., Santiuste, C., Alonso de la Torre, R., Barricarte Gurrea, A., Stocks, T., Johansson, M., Ljungberg, B., Wareham, N., Khaw, K. T., Travis, R. C., Cross, A. J., Murphy, N., Riboli, E., Scelo, G., Jay, Raman, Brennan, P., Brenner, X., Overvad, K., Olsen, A., Tjønneland, A., Boutron-Ruault, M. C., Clavel-Chapelon, F., Fagherazzi, X., Katzke, V., Kühn, T., Boeing, H., Bergmann, M. M., Steffen, A., Naska, A., Trichopoulou, A., Trichopoulos, D., Saieva, C., Grioni, S., Panico, S., Tumino, R., Vineis, P., Bueno-de-Mesquita, H. B., Hjartåker, A., Peeters, P. H., Weiderpass, E., Arriola, L., Molina-Montes, E., Duell, E. J., Santiuste, C., Alonso de la Torre, R., Barricarte Gurrea, A., Stocks, T., Johansson, M., Ljungberg, B., Wareham, N., Khaw, K. T., Travis, R. C., Cross, A. J., Murphy, N., Riboli, E., and Scelo, G.

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results